Patents by Inventor Kristin Forssmann

Kristin Forssmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of a pharmaceutical composition containing at least one digestive enzyme in artificial feeding
    Patent number: 10973886
    Abstract: The invention relates to the use of a pharmaceutical composition in combination with a tube food provided for artificial feeding in the treatment of digestive disorders in case of artificial feeding, where the pharmaceutical composition contains or consists of at least one digestive enzyme, preferably a lipase, particularly preferably a bacterial lipase, most preferably burlulipase (INN) in liquid dosage form, wherein the pharmaceutical composition and the tube food are formulated for being administered simultaneously but separately from each other. The pharmaceutical composition can therefore be administered simultaneously and continuously during the administration of the tube food, but separately from it. As a result, the digestive performance of a patient being artificially fed can be enhanced significantly.
    Type: Grant
    Filed: August 31, 2016
    Date of Patent: April 13, 2021
    Assignee: Nordmark Arzneimittel GmbH & Co. KG
    Inventor: Kristin Forssmann
  • USE OF A PHARMACEUTICAL COMPOSITION CONTAINING AT LEAST ONE DIGESTIVE ENZYME IN ARTIFICIAL FEEDING
    Publication number: 20180236040
    Abstract: The invention relates to the use of a pharmaceutical composition in combination with a tube food provided for artificial feeding in the treatment of digestive disorders in case of artificial feeding, where the pharmaceutical composition contains or consists of at least one digestive enzyme, preferably a lipase, particularly preferably a bacterial lipase, most preferably burlulipase (INN) in liquid dosage form, wherein the pharmaceutical composition and the tube food are formulated for being administered simultaneously but separately from each other. The pharmaceutical composition can therefore be administered simultaneously and continuously during the administration of the tube food, but separately from it. As a result, the digestive performance of a patient being artificially fed can be enhanced significantly.
    Type: Application
    Filed: August 31, 2016
    Publication date: August 23, 2018
    Applicant: Nordmark Arzneimittel GmbH & Co. KG
    Inventor: Kristin FORSSMANN
  • Use of urodilatin for treating chronic kidney failure with residual kidney functions
    Patent number: 6831064
    Abstract: Use of urodilatin for treating chronic renal insufficiency by stimulating the residual renal function.
    Type: Grant
    Filed: July 18, 2002
    Date of Patent: December 14, 2004
    Assignee: Pharis Biotec GmbH
    Inventors: Wolf-Georg Forssmann, Kristin Forssmann, Wolfgang Greb, Markus Meyer